Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1170, pseudogene (RNU6-1170P)
- Target
- RNU6-1170P
- Molecular classification
- Pseudogene, Small nuclear RNA-derived pseudogene
01
Overview
RNU6-1170P is a processed pseudogene in the human genome derived from the U6 small nuclear RNA (snRNA) gene, which plays a critical role in the splicing of pre-mRNA as part of the spliceosome complex. Pseudogenes like RNU6-1170P are the result of retrotransposition events, often mediated by LINE-1 (L1) elements, that create non-functional copies of RNA genes within the genome. U6 snRNA pseudogenes do not encode any functional product and are not therapeutically targetable. They can serve as genomic markers for retrotransposition or genome evolution studies, but do not participate directly in cellular signaling, splicing, or disease-related functions.
- Other names
- RNU6-1170PRNA, U6 small nuclear 1170, pseudogene
02
Mechanism of action
Not applicable; no drugs target this molecule
03
Biological functions
No direct biological function as pseudogenes are non-functional copies of genesU6 snRNA (the progenitor) is involved in pre-mRNA splicing within the spliceosome
04
Disease associations
None documented for RNU6-1170P specifically; however, pseudogenes can sometimes serve as transcriptional regulators or disease biomarkers in rare instances, but no evidence is available for this specific pseudogene
05
Safety considerations
None known. Pseudogenes do not possess known safety concerns or therapeutic challenges as they are generally non-functional
06
Interacting drugs
None known. There are no drugs documented to interact with U6 snRNA pseudogenes, including RNU6-1170P
07
Biomarkers
May theoretically serve as a marker for retrotransposition events in genomic studies, not for patient selection or efficacy monitoring in therapy
Beyond the preview
Go deeper on RNA, U6 small nuclear 1170, pseudogene (RNU6-1170P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1170, pseudogene (RNU6-1170P).